Galanin receptor subtypes
- Trends Pharmacol Sci. 2000 Mar;21(3):109-17. doi: 10.1016/s0165-6147(00)01446-2.
- 1. Synaptic Pharmaceutical Corporation, 215 College Road, Paramus, NJ 07652, USA. [email protected]
The neuropeptide Galanin, which is widely expressed in brain and peripheral tissues, exerts a broad range of physiological effects. Pharmacological studies using peptide analogues have led to speculation about multiple Galanin receptor subtypes. Since 1994, a total of three G-protein-coupled receptor (GPCR) subtypes for Galanin have been cloned (GAL1, gal2 and gal3). Potent, selective antagonists are yet to be found for any of the cloned receptors. Major challenges in this field include linking the receptor clones with each of the known physiological actions of Galanin and evaluating the evidence for additional Galanin receptor subtypes.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: Neuropeptide Y ReceptorResearch Areas: Metabolic Disease
-
target: Neuropeptide Y ReceptorResearch Areas: Metabolic Disease